As of 2026-06-18, the Intrinsic Value of Vivanza Biosciences Ltd (530057.BO) is 16.82 INR. This 530057.BO valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 1.92 INR, the upside of Vivanza Biosciences Ltd is 775.80%.
The range of the Intrinsic Value is 6.52 - 39.36 INR
Based on its market price of 1.92 INR and our intrinsic valuation, Vivanza Biosciences Ltd (530057.BO) is undervalued by 775.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (17.46) - (16.66) | (16.99) | -985.0% |
| DCF (Growth 10y) | 6.52 - 39.36 | 16.82 | 775.8% |
| DCF (EBITDA 5y) | 40.87 - 77.18 | 57.50 | 2894.8% |
| DCF (EBITDA 10y) | 82.77 - 170.37 | 120.65 | 6183.8% |
| Fair Value | 2.47 - 2.47 | 2.47 | 28.42% |
| P/E | 0.64 - 8.16 | 3.12 | 62.4% |
| EV/EBITDA | 1.21 - 3.52 | 1.94 | 1.1% |
| EPV | 1.40 - 3.19 | 2.29 | 19.5% |
| DDM - Stable | 0.44 - 0.96 | 0.70 | -63.6% |
| DDM - Multi | 16.48 - 30.03 | 21.47 | 1018.4% |
| Market Cap (mil) | 76.80 |
| Beta | 1.48 |
| Outstanding shares (mil) | 40.00 |
| Enterprise Value (mil) | 178.06 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.50% |
| Cost of Debt | 7.85% |
| WACC | 9.78% |